Compare VRXAW & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
Current Price
| Metric | VRXAW | FTAIM |
|---|---|---|
| Founded | N/A | N/A |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Corporate Leasing Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | 2014 |
| Metric | VRXAW | FTAIM |
|---|---|---|
| Price | $0.10 | $27.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.7K | 2.3K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1537.50 |
| EPS | N/A | ★ 2.42 |
| Revenue | N/A | ★ $2,507,409,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.33 |
| Revenue Growth | N/A | ★ 44.53 |
| 52 Week Low | $0.07 | $26.31 |
| 52 Week High | $0.23 | $27.81 |
| Indicator | VRXAW | FTAIM |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 48.39 |
| Support Level | $0.09 | $26.58 |
| Resistance Level | $0.12 | $27.43 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 62.77 | 34.92 |
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.